Who Are We?
iSolve’s ADLT™ Platform was designed to solve two problems that our target markets (BioPharma, Healthcare, Medical Device Manufacturers and Lifesciences ) face: data silos and lack of data provenance. ADLT™ provides an interoperable solution to facilitate secure data transfer and create the provenance of data that is required for business or regulatory reasons. It is Blockchain Agnostic, but we believe that enterprise solutions like Hyperledger, Corda, and Enterprise Ethereum etc will be the preferred choice for our Enterprise Clients.
Our patent-pending solution can solve a wide range of issues including Global Supply Chain Track and Trace, R&D, Clinical Trials, and the movement of patient medical records. We have presented a POC to the FDA, World Bank, Industry and are working on several innovative and patient-focused applications.
iSolve created its Advanced Digital Ledger Technology™ (ADLT™) platform to break down data silos by creating an interoperable platform that is complementary to existing systems and processes and can incorporate new technology like IoMT and facilitate Machine Learning and Big Data. By focusing on creating a network of Trusted Partners that are incentivized, ADLT™ provides the solutions for facilitating the transfer of information and creating new revenue models.
The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes.